BVXV Stock Price, News & Analysis

bvxv

Company Description

Welcome to the overview page for BVXV (bvxv), where you can find comprehensive stock information and company updates.

Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.

Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.

Stock Performance

$—

0.00%

0.00

Last updated:

-

Performance 1 year

$0.0

0.0

Shares outstanding

Latest News

April 10, 2024

0.00%

Scinai to showcase its novel biological local therapeutic for Plaque Psoriasis at Dermatology Drug Development Summit together with Prof. Michael Schön of UMG

March 12, 2024

0.00%

Scinai leadership to attend BIO-Europe Spring 2024

conferences

February 13, 2024

0.00%

Scinai Welcomes Liat Halpert as Head of Business Development and Sales

January 4, 2024

0.00%

Scinai Immunotherapeutics Announces Closing of Exercise of Outstanding Warrants for $1.69 Million in Gross Proceeds

offering

November 20, 2023

0.00%

Scinai Immunotherapeutics Regains Compliance with Nasdaq's Stockholders' Equity Rule

September 6, 2023

3.82%

BiondVax Pharmaceuticals Ltd. Rebrands as Scinai Immunotherapeutics Ltd. to Reflect New Focus on Development of Novel Inflammation and Immunology (I&I) Biological Therapeutics

SEC Filings

No SEC filings available for BVXV.

Financial Highlights

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Loading short interest data...

Days to Cover History

Last 12 Months

Loading days to cover data...